Limitations, agreements, and source contact

Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck · Source last updated 2024-07-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

xle1@mdanderson.org

organization

UT MD Anderson Cancer Center

phone

(713) 792-6980

title

Dr. Xiuning Le, MD, Assistant Professor, Thoracic-Head & Neck Med Onc

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice